China’s JD.com, Meituan and Neolix on Tuesday obtained approval to test their self-driving delivery vehicles on designated public roads within the Beijing Economic and Technological Development Area, in southeastern Beijing’s Yizhuang area, which marks another breakthrough in the country’s autonomous-driving sector toward commercialization.
China science, technology news summary May 26
Xinhua
26 May 2021, 14:05 GMT+10
BEIJING, May 26 (Xinhua) The following is a summary of published science and technology news of China. HARMONYOS SYSTEM Chinese telecom giant Huawei will officially launch its new operating system HarmonyOS for smartphones on June 2, the company said Tuesday. HarmonyOS, or Hongmeng in Chinese, is an open-source operating system designed for various devices and scenarios. It was first launched on Internet-of-Things devices including wearables and tablets in August 2019. Huawei expects the number of devices equipped with HarmonyOS to reach 300 million by the end of 2021, including more than 200 million for Huawei devices.
Unmanned delivery vehicles to hit Beijing roads ecns.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ecns.cn Daily Mail and Mail on Sunday newspapers.
2021-05-25 14:50:48 GMT2021-05-25 22:50:48(Beijing Time) Xinhua English
BEIJING, May 25 (Xinhua) Three companies on Tuesday were given permits to run their unmanned delivery vehicles on designated open roads in Beijing, the first time the Chinese capital will allow such vehicles.
The e-commerce giant JD.com, the online service company Meituan, and the autonomous driving vehicle producer Neolix received ID numbers for these vehicles at the eighth international congress of intelligent connected vehicles technology in Beijing.
The vehicles will drive at the Beijing high-level autonomous driving demonstration area, which covers 60 square km at the Beijing Economic-Technological Development Area, also known as E-Town, in Daxing District.
Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5% to RMB1.91 Billion
Contribution of Sales of New Products to Revenue Rises to 47.4%
Driving Revenue Up by 16.4%
HONG KONG, May 24, 2021 - (ACN Newswire) - Sino Biopharmaceutical Limited ( Sino Biopharmaceutical or the Company , together with its subsidiaries, the Group ) (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2021.
Development Highlights Chia Tai - Tianqing Pharmaceutical Group Co. Ltd. ( CT Tianqing ), a member company of the Group, and Beijing-based Genetron Holdings Limited (NASDAQ: GTH) signed a strategic cooperation agreement on early screening of liver cancer. The two parties will work together in the next three years in selected areas in the country to serve those at high risk of developing liver cancer, including Hepatitis B carriers a